Radiolabeled compounds targeting the prostate-specific membrane antigen Grant US-11504441-B2 United States of America 22 Nov 2022
99MTC-EDDA/HYNIC-IPSMA AS A RADIOPHARMACEUTICAL FOR DETECTING THE OVEREXPRESSION OF… Application EP-4083049-A2 European Patent Office 02 Nov 2022
18/19F-labelled compounds which target the prostate specific membrane antigen Grant US-10882871-B2 United States of America 05 Jan 2021
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy Grant US-10688200-B2 United States of America 23 Jun 2020